Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$209.01 - $232.56 $124,151 - $138,140
594 Added 3.41%
17,997 $3.93 Million
Q4 2023

Jan 31, 2024

BUY
$197.69 - $227.29 $4,744 - $5,454
24 Added 0.14%
17,403 $3.96 Million
Q3 2023

Oct 25, 2023

BUY
$201.05 - $221.7 $33,977 - $37,467
169 Added 0.98%
17,379 $3.49 Million
Q2 2023

Aug 01, 2023

BUY
$211.93 - $241.33 $19,497 - $22,202
92 Added 0.54%
17,210 $4.15 Million
Q1 2023

Apr 28, 2023

SELL
$213.32 - $257.83 $20,692 - $25,009
-97 Reduced 0.56%
17,118 $3.93 Million
Q4 2022

Jan 27, 2023

BUY
$203.72 - $248.97 $34,632 - $42,324
170 Added 1.0%
17,215 $4.05 Million
Q3 2022

Oct 28, 2022

SELL
$204.81 - $262.19 $12,493 - $15,993
-61 Reduced 0.36%
17,045 $3.49 Million
Q2 2022

Jul 28, 2022

BUY
$213.86 - $277.87 $10,693 - $13,893
50 Added 0.29%
17,106 $4.01 Million
Q1 2022

Apr 27, 2022

SELL
$259.82 - $298.18 $70,151 - $80,508
-270 Reduced 1.56%
17,056 $4.5 Million
Q4 2021

Feb 10, 2022

BUY
$271.6 - $314.21 $76,319 - $88,293
281 Added 1.65%
17,326 $5.44 Million
Q3 2021

Oct 28, 2021

BUY
$274.82 - $308.34 $238,543 - $267,639
868 Added 5.37%
17,045 $4.8 Million
Q2 2021

Jul 27, 2021

BUY
$251.87 - $278.14 $205,274 - $226,684
815 Added 5.31%
16,177 $4.46 Million
Q1 2021

Apr 27, 2021

BUY
$204.88 - $255.03 $98,752 - $122,924
482 Added 3.24%
15,362 $3.92 Million
Q4 2020

Jan 26, 2021

BUY
$186.91 - $214.42 $60,932 - $69,900
326 Added 2.24%
14,880 $3.03 Million
Q3 2020

Oct 29, 2020

BUY
$167.03 - $201.3 $11,692 - $14,091
70 Added 0.48%
14,554 $2.74 Million
Q2 2020

Jul 29, 2020

BUY
$113.31 - $182.44 $165,772 - $266,909
1,463 Added 11.24%
14,484 $2.41 Million
Q1 2020

Apr 22, 2020

SELL
$104.32 - $195.28 $158,044 - $295,849
-1,515 Reduced 10.42%
13,021 $1.65 Million
Q4 2019

Jan 24, 2020

SELL
$163.48 - $173.61 $25,502 - $27,083
-156 Reduced 1.06%
14,536 $2.46 Million
Q3 2019

Oct 29, 2019

SELL
$159.77 - $178.1 $5,432 - $6,055
-34 Reduced 0.23%
14,692 $2.47 Million
Q2 2019

Aug 01, 2019

SELL
$144.16 - $172.9 $11,100 - $13,313
-77 Reduced 0.52%
14,726 $2.55 Million
Q1 2019

Apr 23, 2019

BUY
$123.7 - $156.3 $9,772 - $12,347
79 Added 0.54%
14,803 $2.27 Million
Q4 2018

Jan 22, 2019

BUY
$120.82 - $174.09 $1.78 Million - $2.56 Million
14,724 New
14,724 $1.86 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.6B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Eukles Asset Management Portfolio

Follow Eukles Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eukles Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Eukles Asset Management with notifications on news.